Today: The ICU Medical Inc. (ICUI) Director Sold $210,900.00 in Stock

The ICU Medical Inc. (ICUI) Director Sold $210,900.00 in Stock

ICU Medical Inc. (NASDAQ:ICUI) Director Richard Md Sherman sold 1,500 shares of ICU Medical stock in a transaction dated Thursday, October 6th. The stock was sold at an average price of $140.60, for a total value of $210,900.00. Following the transaction, the director now directly owns 70,699 shares in the company, valued at $9,940,279.40. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Richard Md Sherman also recently made the following trade(s): On Monday, September 19th, Richard Md Sherman sold 3,000 shares of ICU Medical stock. The stock was sold at an average price of $122.51, for a total value of $367,530.00.

ICU Medical Inc. (NASDAQ:ICUI) opened at 149.65 on Friday. ICU Medical Inc. has a 52 week low of $85.56 and a 52 week high of $150.37. The company has a 50-day moving average price of $126.14 and a 200-day moving average price of $112.44. The stock has a market cap of $2.41 billion, a PE ratio of 44.57 and a beta of 0.37.

10/08/icu-medical-inc-icui-director-sells-210900-00-in-stock.html

ICU Medical (NASDAQ:ICUI) last posted its quarterly earnings data on Monday, August 8th. The company reported $1.15 EPS for the quarter, topping analysts’ consensus estimates of $1.05 by $0.10. The company had revenue of $96.70 million for the quarter, compared to analyst estimates of $89.66 million. ICU Medical had a return on equity of 10.33% and a net margin of 14.94%. The business’s revenue was up 15.4% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.97 earnings per share. Analysts anticipate that ICU Medical Inc. will post $4.54 earnings per share for the current year.

A number of brokerages recently weighed in on ICUI. Piper Jaffray Cos. reissued a “neutral” rating and issued a $119.00 price target (up previously from $115.00) on shares of ICU Medical in a research note on Thursday, August 11th. Zacks Investment Research raised ICU Medical from a “hold” rating to a “buy” rating and set a $140.00 price target on the stock in a research note on Friday, August 12th.

Institutional investors have recently bought and sold shares of the company. Virginia Retirement System acquired a new position in ICU Medical during the first quarter worth approximately $333,000. Teachers Advisors Inc. raised its position in ICU Medical by 13.3% in the first quarter. Teachers Advisors Inc. now owns 202,753 shares of the company’s stock worth $21,107,000 after buying an additional 23,812 shares in the last quarter. JPMorgan Chase & Co. raised its position in ICU Medical by 63.5% in the first quarter. JPMorgan Chase & Co. now owns 185,078 shares of the company’s stock worth $19,267,000 after buying an additional 71,891 shares in the last quarter. Menta Capital LLC raised its position in ICU Medical by 157.1% in the first quarter. Menta Capital LLC now owns 5,400 shares of the company’s stock worth $562,000 after buying an additional 3,300 shares in the last quarter. Finally, M&T Bank Corp raised its position in ICU Medical by 3.3% in the first quarter. M&T Bank Corp now owns 2,117 shares of the company’s stock worth $220,000 after buying an additional 67 shares in the last quarter. 89.50% of the stock is currently owned by institutional investors.

About ICU Medical

Related posts

Leave a Comment